The Uttar Pradesh government is setting up a pharma park in Lalitpur, Bundelkhand, covering 1,472-acre across five...
Read More
The U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace...
Read More
Drugmaker Lupin said its Swiss subsidiary, Lupin Atlantis Holdings SA, had signed an Asset Purchase Agreement with...
Read More
The U.S. health regulator has placed a clinical hold on Iovance Biotherapeutics' (IOVA.O) trial of its experimental cell...
Read More
The drugs regulator in India has banned the use of an anti-cold drug combination in children aged below four and ordered...
Read More
The acquisition is a strategic investment to support the development of innovative pharmaceutical delivery technologies...
Read More
The Biden administration said on Thursday it had identified 48 drugs in the Medicare program whose prices rose quicker...
Read More
Taro's special committee evaluating the proposal has agreed in principle to the revised proposal and to negotiate...
Read More
A new highly fluorescent material with exceptional optical properties has been developed using phosphorene, cystine, and...
Read More
Private equity firm Blackstone Group Inc. has acquired a controlling interest in Care Hospitals and Kims Health in a $1...
Read More
Of all the biologics markets in the world, India will witness the fastest rates of overall growth in biologicals over...
Read More
An injected version of Eisai (4523.T) and Biogen's (BIIB.O) Alzheimer's drug Leqembi works as well as the current...
Read More